Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →

At a glance

Works on
Professional highlights appear here once this profile is claimed. Claim it →

Background

Career

The past 12 months

Clients
1
past 12 months
Filings
1
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESHealth & Human Services, Dept of (HHS)SENATE

Specific issues

Appropriations impacting patients with rare diseases. National Institutes of Health (NIH) NCATS Appropriations.
Budget/Appropriations · 2026 Q2
Medicare / Medicaid issues impacting patients with rare diseases.
Medicare/Medicaid · 2026 Q2
Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. Prescription Drug User Fee Act (PDUFA) Reauthorization. User Fee Agreements.
Pharmacy · 2026 Q2
Rare Disease Initiatives. Newborn Screening. Genetic Testing Access. Medical Nutrition Equity Act. Medical Foods and Formulas Act. Orphan Drug Act.
Health Issues · 2026 Q2

Clients

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings1
2026 Q2
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
Q2lda.gov →